- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 1400 Pages
Global
From €4292EUR$4,900USD£3,725GBP
- Report
- November 2025
- 187 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- November 2025
- 109 Pages
Global
From €3022EUR$3,450USD£2,623GBP
- Report
- September 2025
- 150 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 134 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 132 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 130 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- April 2025
- 205 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2025
- 200 Pages
United States
From €2181EUR$2,490USD£1,893GBP
- Report
- August 2025
- 125 Pages
United States
From €3459EUR$3,950USD£3,003GBP
- Report
- July 2025
- 125 Pages
United States
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 175 Pages
Middle East, Africa
From €3722EUR$4,250USD£3,231GBP
- Report
- January 2026
- 95 Pages
Europe
From €4160EUR$4,750USD£3,611GBP
- Report
- May 2025
- 70 Pages
United States
From €4160EUR$4,750USD£3,611GBP

The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more